In laboratory experiments, isolated cells expressing CCL20 and CCR4, stimulated by IL-5 and IL-7, demonstrated an increased ability of CD8+ T cells to penetrate dysplastic cells, thereby improving therapeutic efficiency in fighting dysplasia. The gene discussed is CCR4; the disease is dysplasia.